United States Biotechnology & Medical Research

Capricor Therapeutics Inc (CAPR)

Track

Over the past 90 days, Capricor Therapeutics Inc. insiders have executed 12 transactions, all of which were sales totaling approximately $7.36 million. Key executives, including the CFO and General Counsel, conducted these planned sales following the company's recent earnings report, which showed an EPS miss. No insider purchases were recorded during this period.
Ticker: CAPR Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Capricor Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 25 Jun 2026
Value US$4,794,152.30 | Price 173.46 | Shares 27,893 (-25.6%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-29 2026-06-25 PlS Planned sale
Bergmann Anthony

CHIEF FINANCIAL OFFICER

Officer
27,893 -25.6%
173.46
US$4,794,152 		27,893 -25.6% 173.46 US$4,794,152
2026-06-29 2026-06-25 PlS Planned sale
Krasney Karen

EVP, GENERAL COUNSEL

Officer
12,134 +3.7%
426.08
US$4,744,051 		12,134 +3.7% 426.08 US$4,744,051
2026-06-24 2026-06-24 PlS Planned sale
Bergmann Anthony

CHIEF FINANCIAL OFFICER

Officer
7,559 +30.2%
429.01
US$4,531,601 		7,559 +30.2% 429.01 US$4,531,601
2026-06-24 2026-06-24 PlS Planned sale
Krasney Karen

EVP, GENERAL COUNSEL

Officer
400 -1.3%
30.00
US$12,000 		400 -1.3% 30.00 US$12,000
2026-06-24 2026-06-22 PlS Planned sale
Bergmann Anthony

CHIEF FINANCIAL OFFICER

Officer
500 -4.3%
30.00
US$15,000 		500 -4.3% 30.00 US$15,000
2026-06-24 2026-06-22 PlS Planned sale
Krasney Karen

EVP, GENERAL COUNSEL

Officer
500 -1.6%
30.00
US$15,000 		500 -1.6% 30.00 US$15,000
2026-05-19 2026-05-19 PrS Proposed sale
1.5
Musket David B

Director

Non-Executive Director
10,000
27.32
US$273,200 		10,000 27.32 US$273,200
2026-05-19 2026-05-19 PrS Proposed sale
1.5
Musket David B

Director

Non-Executive Director
88,788
27.00
US$2,397,256 		88,788 27.00 US$2,397,256
2026-05-04 2026-05-01 PlS Planned sale
Krasney Karen

EVP, GENERAL COUNSEL

Officer
25,000 -45.0%
31.70
US$792,548 		25,000 -45.0% 31.70 US$792,548
2026-05-04 2026-05-01 PlS Planned sale
Krasney Karen

EVP, GENERAL COUNSEL

Officer
25,000 -45.0%
31.70
US$792,548 		25,000 -45.0% 31.70 US$792,548
2026-05-04 2026-05-01 PlS Planned sale
Bergmann Anthony

CHIEF FINANCIAL OFFICER

Officer
25,000 -75.2%
31.70
US$792,540 		25,000 -75.2% 31.70 US$792,540
2026-05-04 2026-05-01 PlS Planned sale
Bergmann Anthony

CHIEF FINANCIAL OFFICER

Officer
25,000 -75.2%
31.70
US$792,540 		25,000 -75.2% 31.70 US$792,540
2026-04-03 2026-04-02 PlS Planned sale
Sabar Karimah Es
Non-Executive Director
7,529 -100.0%
32.00
US$240,928 		7,529 -100.0% 32.00 US$240,928
2026-04-02 2026-04-02 PrS Proposed sale
Karimah Es Sabar

Director

Non-Executive Director
7,529
30.12
US$226,773 		7,529 30.12 US$226,773
2026-04-01 2026-04-01 PlS Planned sale
Sabar Karimah Es
Non-Executive Director
53,735 -100.0%
31.03
US$1,667,225 		53,735 -100.0% 31.03 US$1,667,225
2026-04-01 2026-03-31 PlS Planned sale
Sabar Karimah Es
Non-Executive Director
61,265 -100.0%
30.17
US$1,848,243 		61,265 -100.0% 30.17 US$1,848,243
2026-04-01 2026-03-31 PlS Planned sale
Krasney Karen

EVP, GENERAL COUNSEL

Officer
25,000 -45.0%
30.12
US$752,935 		25,000 -45.0% 30.12 US$752,935
2026-04-01 2026-03-31 PlS Planned sale
Bergmann Anthony

CHIEF FINANCIAL OFFICER

Officer
25,000 -75.2%
30.13
US$753,152 		25,000 -75.2% 30.13 US$753,152
2026-03-31 2026-03-31 PrS Proposed sale
Karimah Es Sabar

Director

Non-Executive Director
115,000
27.77
US$3,193,550 		115,000 27.77 US$3,193,550
2026-03-31 2026-03-31 PrS Proposed sale
ANTHONY BERGMANN

Officer

Officer
75,000
27.77
US$2,082,750 		75,000 27.77 US$2,082,750
2026-03-31 2026-03-31 PrS Proposed sale
Karen Krasney

Officer

Officer
75,000
27.77
US$2,082,750 		75,000 27.77 US$2,082,750
2024-09-24 2024-09-20 B Purchase
3.4
Nippon Shinyaku Co Ltd
Large shareholder
2,798,507 +65.2%
5.36
US$14,999,998 		2,798,507 +65.2% 5.36 US$14,999,998
2023-10-13 2023-10-12 B Purchase
1.5
Musket David B
Non-Executive Director
410 +1.3%
2.75
US$1,128 		410 +1.3% 2.75 US$1,128
2023-10-12 2023-10-10 B Purchase
2.6
COLLIER EARL M JR
Non-Executive Director
10,000 +59.3%
2.83
US$28,300 		10,000 +59.3% 2.83 US$28,300
2023-10-11 2023-10-09 B Purchase
1.5
Musket David B
Non-Executive Director
5,083 +19.5%
2.82
US$14,334 		5,083 +19.5% 2.82 US$14,334
2023-10-10 2023-10-06 B Purchase
3.1
Auwaerter Paul Gisbert
Non-Executive Director
5,000 +inf%
2.84
US$14,200 		5,000 +inf% 2.84 US$14,200
2023-10-06 2023-10-04 B Purchase
1.5
Musket David B
Non-Executive Director
2,500 +10.6%
2.90
US$7,250 		2,500 +10.6% 2.90 US$7,250
2023-04-27 2023-04-17 S Sale
2.7
Avat Xavier

Former CBO
14,772 -100.0%
64,258.00
US$949,219,176 		14,772 -100.0% 64,258.00 US$949,219,176
2023-04-07 2023-03-28 S Sale
2.7
Avat Xavier
3,000 -100.0%
4.06
US$12,180 		3,000 -100.0% 4.06 US$12,180
2022-07-07 2022-07-06 B Purchase
2.7
Avat Xavier

CHIEF BUSINESS OFFICER

Officer
1,000 +50.0%
3.68
US$3,680 		1,000 +50.0% 3.68 US$3,680
2022-07-07 2022-06-29 B Purchase
2.7
Avat Xavier

CHIEF BUSINESS OFFICER

Officer
1,500 +300.0%
3.76
US$5,643 		1,500 +300.0% 3.76 US$5,643
2022-07-01 2022-06-29 S Sale
1.5
Musket David B
Non-Executive Director
28,215 -68.9%
3.77
US$106,371 		28,215 -68.9% 3.77 US$106,371
2022-06-29 2022-06-27 S Sale
1.5
Musket David B
Non-Executive Director
17,775 -30.3%
4.44
US$78,921 		17,775 -30.3% 4.44 US$78,921
2017-05-11 2017-05-09 B Purchase CEDARS SINAI MEDICAL CENTER Large shareholder
1,145,161 +39.4%
3.10
US$3,549,999 		1,145,161 +39.4% 3.10 US$3,549,999
2017-05-11 2017-05-09 B Purchase Musket David B Non-Executive Director
25,000 +inf%
3.10
US$77,500 		25,000 +inf% 3.10 US$77,500
2017-05-11 2017-05-09 B Purchase Manzo Louis Non-Executive Director
10,000 +7.8%
3.10
US$31,000 		10,000 +7.8% 3.10 US$31,000
2016-09-22 2016-09-21 B Purchase CEDARS SINAI MEDICAL CENTER Large shareholder
312,500 +12.1%
3.20
US$1,000,000 		312,500 +12.1% 3.20 US$1,000,000
2016-03-18 2016-03-16 B Purchase Marban Linda

Chief Executive Officer

Executive Director
10,152 +3.9%
2.40
US$24,365 		10,152 +3.9% 2.40 US$24,365
2016-03-18 2016-03-16 B Purchase CEDARS SINAI MEDICAL CENTER Large shareholder
416,666 +19.2%
2.40
US$999,998 		416,666 +19.2% 2.40 US$999,998
2016-03-18 2016-03-16 B Purchase Krasney Karen

EVP, General Counsel

Officer
4,060 +57.2%
2.40
US$9,744 		4,060 +57.2% 2.40 US$9,744
2016-03-18 2016-03-16 B Purchase GERSHELL LELAND

CHIEF FINANCIAL OFFICER

Officer
2,100 +inf%
2.40
US$5,040 		2,100 +inf% 2.40 US$5,040
2016-03-18 2016-03-16 B Purchase Manzo Louis Non-Executive Director
100,000 +352.3%
2.40
US$240,000 		100,000 +352.3% 2.40 US$240,000
2016-03-18 2016-03-16 B Purchase Bergmann Anthony

Vice President of Finance

Officer
2,030 +inf%
2.40
US$4,872 		2,030 +inf% 2.40 US$4,872
2016-03-18 2016-03-16 B Purchase St. John Edward A. Large shareholder
416,666 +97.9%
2.40
US$999,998 		416,666 +97.9% 2.40 US$999,998
2016-03-18 2016-03-16 B Purchase St. John Edward A. Large shareholder
416,666 +97.9%
2.40
US$999,998 		416,666 +97.9% 2.40 US$999,998
2016-03-18 2016-03-16 B Purchase GRASMICK LOUIS J Non-Executive Director
20,304 +2.0%
2.40
US$48,730 		20,304 +2.0% 2.40 US$48,730
2016-03-18 2016-03-16 B Purchase GRASMICK LOUIS J Non-Executive Director
71,065 +1194.4%
2.40
US$170,556 		71,065 +1194.4% 2.40 US$170,556
2015-08-21 2015-08-20 B Purchase GRASMICK LOUIS J Non-Executive Director
4,630 +350.8%
4.08
US$18,877 		4,630 +350.8% 4.08 US$18,877
2015-08-21 2015-08-20 B Purchase GRASMICK LOUIS J Non-Executive Director
4,630 +350.8%
4.08
US$18,877 		4,630 +350.8% 4.08 US$18,877
2015-08-21 2015-08-19 B Purchase GRASMICK LOUIS J Non-Executive Director
1,320 +inf%
4.22
US$5,570 		1,320 +inf% 4.22 US$5,570
2015-08-21 2015-08-19 B Purchase GRASMICK LOUIS J Non-Executive Director
1,320 +inf%
4.22
US$5,570 		1,320 +inf% 4.22 US$5,570
2015-08-20 2015-08-19 B Purchase Marban Linda

Chief Executive Officer

Executive Director
4,200 +0.1%
4.42
US$18,564 		4,200 +0.1% 4.42 US$18,564
2015-08-20 2015-08-19 B Purchase Marban Linda

Chief Executive Officer

Executive Director
4,200 +1.6%
4.42
US$18,564 		4,200 +1.6% 4.42 US$18,564
2015-08-20 2015-08-19 B Purchase Marban Eduardo Large shareholder
4,200 +1.6%
4.42
US$18,564 		4,200 +1.6% 4.42 US$18,564
2015-08-20 2015-08-19 B Purchase Marban Eduardo Large shareholder
4,200 +0.1%
4.42
US$18,564 		4,200 +0.1% 4.42 US$18,564
2015-08-20 2015-08-18 B Purchase Marban Linda

Chief Executive Officer

Executive Director
5,000 +0.2%
4.31
US$21,550 		5,000 +0.2% 4.31 US$21,550
2015-08-20 2015-08-18 B Purchase Marban Eduardo Large shareholder
5,000 +1.9%
4.31
US$21,550 		5,000 +1.9% 4.31 US$21,550
2015-08-20 2015-08-18 B Purchase Marban Linda

Chief Executive Officer

Executive Director
5,000 +1.9%
4.31
US$21,550 		5,000 +1.9% 4.31 US$21,550
2015-08-20 2015-08-18 B Purchase Marban Eduardo Large shareholder
5,000 +0.2%
4.31
US$21,550 		5,000 +0.2% 4.31 US$21,550
2015-01-23 2015-01-21 B Purchase St. John Edward A. Large shareholder
425,773 +inf%
3.52
US$1,499,998 		425,773 +inf% 3.52 US$1,499,998
2015-01-23 2015-01-21 B Purchase St. John Edward A. Large shareholder
425,773 +inf%
3.52
US$1,499,998 		425,773 +inf% 3.52 US$1,499,998
2015-01-22 2015-01-21 B Purchase CEDARS SINAI MEDICAL CENTER Large shareholder
851,546 +64.3%
3.52
US$2,999,997 		851,546 +64.3% 3.52 US$2,999,997
2015-01-22 2015-01-21 B Purchase Kazam Joshua A Non-Executive Director
7,096 +22.9%
3.52
US$24,999 		7,096 +22.9% 3.52 US$24,999
2015-01-22 2015-01-21 B Purchase Krasney Karen

EVP, General Counsel

Officer
7,096 +inf%
3.52
US$24,999 		7,096 +inf% 3.52 US$24,999
2015-01-22 2015-01-21 B Purchase GRASMICK LOUIS J Non-Executive Director
141,924 +15.8%
3.52
US$499,998 		141,924 +15.8% 3.52 US$499,998
2015-01-22 2015-01-21 B Purchase Manzo Louis Non-Executive Director
28,384 +inf%
3.52
US$99,997 		28,384 +inf% 3.52 US$99,997
2015-01-22 2015-01-21 B Purchase Musket David B Non-Executive Director
70,962 +inf%
3.52
US$249,999 		70,962 +inf% 3.52 US$249,999
2009-03-13 2009-03-13 B Purchase Evans Daron

Chief Financial Officer

Officer
5,000 +119.0%
0.75
US$3,750 		5,000 +119.0% 0.75 US$3,750
2009-03-13 2009-03-12 B Purchase Kazam Joshua A Non-Executive Director
510 +0.0%
0.75
US$382 		510 +0.0% 0.75 US$382
2009-03-13 2009-03-11 B Purchase Evans Daron

Chief Financial Officer

Officer
6,000 +142.9%
0.77
US$4,620 		6,000 +142.9% 0.77 US$4,620
2008-12-16 2008-12-16 B Purchase Kazam Joshua A Non-Executive Director
3,100 +0.3%
1.15
US$3,565 		3,100 +0.3% 1.15 US$3,565
2008-12-16 2008-12-16 B Purchase TANEN DAVID M Non-Executive Director
2,500 +0.2%
1.15
US$2,875 		2,500 +0.2% 1.15 US$2,875
2008-12-15 2008-12-15 B Purchase TANEN DAVID M Non-Executive Director
2,480 +0.2%
1.05
US$2,604 		2,480 +0.2% 1.05 US$2,604
2008-12-15 2008-12-15 B Purchase TANEN DAVID M Non-Executive Director
20 +0.0%
1.04
US$21 		20 +0.0% 1.04 US$21
2008-12-15 2008-12-15 B Purchase Kazam Joshua A Non-Executive Director
2,500 +0.2%
1.05
US$2,625 		2,500 +0.2% 1.05 US$2,625
Explore more

More insider trading research around Capricor Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America